Correction: Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma - Zhu, Yan; He, Cheng; Cao, Shi-Chao; Li, Hui-Jun; Cai, Ru-Xue; Bai, Zhao-Jun; Xia, Tong-Xia (Frontiers in Pharmacology, 2025)